Bank of Nova Scotia’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18M | Buy |
38,031
+12,749
| +50% | +$6.42M | 0.03% | 317 |
|
|
2025
Q4 | $11.8M | Buy |
25,282
+4,227
| +20% | +$1.96M | 0.02% | 447 |
|
|
2025
Q3 | $8.97M | Buy |
21,055
+2,506
| +14% | +$971K | 0.02% | 438 |
|
|
2025
Q2 | $7.11M | Sell |
18,549
-513
| -3% | -$185K | 0.01% | 446 |
|
|
2025
Q1 | $6.59M | Sell |
19,062
-105,670
| -85% | -$34M | 0.01% | 418 |
|
|
2024
Q4 | $37.4M | Buy |
124,732
+71,441
| +134% | +$25M | 0.07% | 207 |
|
|
2024
Q3 | $21.7M | Buy |
53,291
+32,888
| +161% | +$12M | 0.04% | 224 |
|
|
2024
Q2 | $6.56M | Sell |
20,403
-49,371
| -71% | -$16M | 0.01% | 424 |
|
|
2024
Q1 | $23.3M | Sell |
69,774
-43,022
| -38% | -$13.1M | 0.05% | 246 |
|
|
2023
Q4 | $30.5M | Buy |
112,796
+40,790
| +57% | +$10.1M | 0.06% | 226 |
|
|
2023
Q3 | $17.7M | Buy |
72,006
+55,235
| +329% | +$15.1M | 0.05% | 237 |
|
|
2023
Q2 | $5.09M | Buy |
16,771
+2,145
| +15% | +$596K | 0.01% | 366 |
|
|
2023
Q1 | $3.86M | Sell |
14,626
-3,173
| -18% | -$806K | 0.01% | 419 |
|
|
2022
Q4 | $4.27M | Sell |
17,799
-366
| -2% | -$82K | 0.01% | 496 |
|
|
2022
Q3 | $3.34M | Sell |
18,165
-928
| -5% | -$185K | 0.01% | 512 |
|
|
2022
Q2 | $3.21M | Sell |
19,093
-15,199
| -44% | -$3.27M | 0.01% | 585 |
|
|
2022
Q1 | $8.6M | Sell |
34,292
-68,557
| -67% | -$17.2M | 0.01% | 484 |
|
|
2021
Q4 | $26.4M | Buy |
102,849
+51,974
| +102% | +$12.7M | 0.04% | 335 |
|
|
2021
Q3 | $12.3M | Buy |
50,875
+14,619
| +40% | +$3.57M | 0.02% | 436 |
|
|
2021
Q2 | $7.5M | Sell |
36,256
-76,696
| -68% | -$15.6M | 0.01% | 501 |
|
|
2021
Q1 | $21.3M | Buy |
112,952
+73,322
| +185% | +$12.9M | 0.04% | 290 |
|
|
2020
Q4 | $6.52M | Sell |
39,630
-691,735
| -95% | -$101M | 0.01% | 446 |
|
|
2020
Q3 | $91.2M | Sell |
731,365
-83,378
| -10% | -$10.3M | 0.25% | 95 |
|
|
2020
Q2 | $79.1M | Buy |
814,743
+314,609
| +63% | +$32.7M | 0.27% | 84 |
|
|
2020
Q1 | $44.9M | Buy |
500,134
+232,711
| +87% | +$30.1M | 0.15% | 127 |
|
|
2019
Q4 | $39.5M | Buy |
267,423
+213,600
| +397% | +$28.7M | 0.1% | 188 |
|
|
2019
Q3 | $6.48M | Sell |
53,823
-121,973
| -69% | -$15.8M | 0.02% | 449 |
|
|
2019
Q2 | $23.8M | Sell |
175,796
-7,075
| -4% | -$895K | 0.1% | 197 |
|
|
2019
Q1 | $23.8M | Sell |
182,871
-374,555
| -67% | -$50.3M | 0.09% | 212 |
|
|
2018
Q4 | $69.4M | Buy |
557,426
+465,293
| +505% | +$62.5M | 0.32% | 73 |
|
|
2018
Q3 | $12.8M | Buy |
92,133
+61,432
| +200% | +$7.65M | 0.06% | 273 |
|
|
2018
Q2 | $3.15M | Sell |
30,701
-5,009
| -14% | -$507K | 0.02% | 414 |
|
|
2018
Q1 | $3.46M | Sell |
35,710
-8,864
| -20% | -$860K | 0.02% | 452 |
|
|
2017
Q4 | $3.92M | Sell |
44,574
-5,470
| -11% | -$439K | 0.02% | 446 |
|
|
2017
Q3 | $3.98M | Sell |
50,044
-14,609
| -23% | -$1.17M | 0.02% | 420 |
|
|
2017
Q2 | $5.64M | Sell |
64,653
-1,441
| -2% | -$122K | 0.03% | 407 |
|
|
2017
Q1 | $5.88M | Buy |
66,094
+59,480
| +899% | +$4.96M | 0.03% | 388 |
|
|
2016
Q4 | $490K | Buy |
6,614
+500
| +8% | +$37.4K | ﹤0.01% | 613 |
|
|
2016
Q3 | $462K | Buy |
6,114
+20
| +0.3% | +$1.53K | ﹤0.01% | 538 |
|
|
2016
Q2 | $469K | Buy |
6,094
+220
| +4% | +$17.4K | ﹤0.01% | 507 |
|
|
2016
Q1 | $458K | Sell |
5,874
-175,050
| -97% | -$12.2M | ﹤0.01% | 494 |
|
|
2015
Q4 | $12.2M | Buy |
180,924
+174,980
| +2,944% | +$12.2M | 0.06% | 161 |
|
|
2015
Q3 | $460K | Buy |
5,944
+704
| +13% | +$62.3K | ﹤0.01% | 444 |
|
|
2015
Q2 | $475K | Buy |
5,240
+40
| +0.8% | +$3.21K | ﹤0.01% | 376 |
|
|
2015
Q1 | $391K | Sell |
5,200
-124,800
| -96% | -$8.96M | ﹤0.01% | 417 |
|
|
2014
Q4 | $9.54M | Buy |
+130,000
| New | +$9.14M | 0.04% | 159 |
|
|
2014
Q3 | – | Sell |
-300,000
| Closed | -$16.9M | – | 572 |
|
|
2014
Q2 | $16.9M | Buy |
+300,000
| New | +$15.8M | 0.07% | 118 |
|
Other funds holding HCA
VCM
VPM
Bank of Nova Scotia's HCA Position: Q1 2026 in Review
Bank of Nova Scotia increased its HCA Healthcare (HCA) stake by 50% in Q1 2026, buying an estimated $6.42M and bringing the position to 38,031 shares worth $18M. The position accounts for 0.03% of the portfolio, ranked #317.
Bank of Nova Scotia first reported a position in HCA in Q2 2014 and has held it in 47 quarters since. The position peaked at $91.2M in Q3 2020. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Bank of Nova Scotia held 38,031 shares of HCA Healthcare worth $18M as of Q1 2026.
- Bank of Nova Scotia bought 12,749 HCA Healthcare shares in Q1 2026, an estimated $6.42M.
- HCA Healthcare made up 0.03% of Bank of Nova Scotia's portfolio in Q1 2026, its #317 holding.
- Bank of Nova Scotia first reported a position in HCA Healthcare in Q2 2014 and has held it in 47 quarters since.
- Bank of Nova Scotia's HCA Healthcare position peaked at $91.2M in Q3 2020.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.